# TRIGEMINA INC: Form D filings

TRIGEMINA INC, a pharmaceuticals company in Mountain View, CA, filed 2 Form D notices with the SEC between 2009 and 2010. The latest, on November 18, 2010, reports $400,000 sold of a $2 million offering to 6 investors.

Find out what TRIGEMINA INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20TRIGEMINA%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=TRIGEMINA%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Ftrigemina-inc-1385405)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20TRIGEMINA%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=TRIGEMINA%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Ftrigemina-inc-1385405)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 809-B CUESTA DRIVE STE 109, Mountain View, CA, 94040
- Phone: (650) 303-6140
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2006
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1385405

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 18, 2010 | New notice | $2,000,000 | $400,000 | $1,600,000 | 6 | Nov 5, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1385405/000138540510000001/0001385405-10-000001-index.htm) |
| Dec 23, 2009 | New notice | $999,024 | $304,967 | $694,057 | 3 | Dec 8, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1385405/000138540509000003/0001385405-09-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Daniel Jacobs | Executive Officer, Director |  |
| Urs Holzle | Director |  |
| Mark Benham | Director |  |
| Mark McCamish | Director |  |

## Other pharmaceuticals companies in California that filed recently

- [Anvion Bio, Inc.](https://specstream.ai/data/form-d/company/anvion-bio-inc-2158000) $100,000 · Oct 7, 2026
- [Aqur Biosciences, Inc.](https://specstream.ai/data/form-d/company/aqur-biosciences-inc-2094075) $1.5 million · Sep 18, 2026
- [BTB Therapeutics, Inc.](https://specstream.ai/data/form-d/company/btb-therapeutics-inc-2055053) $8.9 million · Aug 12, 2026

[Every Form D from the week of Nov 15, 2010](https://specstream.ai/data/form-d/week/2010-11-15) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what TRIGEMINA INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).